Back to results
US 2010/0305088 A1Published application
INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3
AssigneeSanofi-Aventis
InventorsDavid S. Thorpe, Martin Smrcina, Dagmar D. Cabel
Life of this patent
Estimating the term…
Abstract
This invention is directed to a 3-(amido or sulphamido)-4-(4-substituted-azinyl)benzamide or benzsulphonamide compound as defined herein. The 3-(amido or sulphamido)-(4-substituted-azinyl)benzamide or benzsulphonamide compound is useful as a inhibitor of the chemokine receptor CxCR3, and for preventing or treating a CxCR3 chemokine receptor mediated disease or condition related thereto in a patient in need of such.
Claims20
A 3-(amido or sulphamido)-4-(4-substituted-azinyl)benzamide or benzsulphonamide compound of formula I
- wherein
- Q and Q1 are independently CO or SO2;
- Y is CO or SO2;
- X is halo;
- m is 1, 2 or 3;
- R1 is (optionally substituted (aromatic or lower cyclyl)) lower alkyl C1-3;
- R2, R4 and R6 are independently H or optionally substituted lower alkyl;
- R3 is optionally substituted aromatic group;
- A is CH or N, or A and R5 taken together form a 4-7 membered spiro azaheterocyclyl of the following formula
- n and p are independently 0, 1, 2, 3, 4 or 5, so long as n and p≧2 but ≦5;
- R5 is JGZ, R8R7NQ1 lower alkyl or optionally substituted 3-7 membered azaheterocyclyl;
- Z is bond, CO or SO2;
- G is lower alkyl, C3-7 cycloalkyl or 3-7 membered heterocyclyl;
- and
- J is aromatic group, lower alkoxycarbonyl, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, lower alkoxy, R8R7N or optionally (lower alkyl or halo) substituted 3-7 membered heterocyclyl;
- R7 and R8 are independently H or lower alkyl;
- R9 and R10 are independently H or lower alkyl;
- or
- a pharmaceutically acceptable salt, solvate, N-oxide, quarternary derivative or prodrug thereof, or any combination thereof.
16 more elements
Dependencies are inferred from the claim text.